Terns Pharmaceuticals
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1065 E Hillsdale Blvd Ste 100, Foster Ci...Phone Number
(650) 525-5535Website
www.ternspharma.comRevenue
-Stock Symbol
TERNIndustry
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR- agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com.Explore more
Terns Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Terns Pharmaceuticals
Compare insights from companies similar to Terns Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$31.5M
51-200
Public
$458.6M
2018
SC
Sushmita ChandaExecutive Vice President & Chief Development Officer
Terns Pharmaceuticals Tech Stack
A closer look at the technologies used by Terns Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Terns Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR... Read More
